1-3 of 3
Josh Gustafson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Translation of SC-DARIC33: A Pharmacologically Controlled CD33-Targeted Anti-AML CAR T Cell Product Regulated By Low Nanomolar Concentrations of Rapamycin

Jacob S. Appelbaum, April Price, Joy Zhang, Kaori Oda, Sumati Sundaram, Paula Lewis, Sanela Bilic, Giacomo Tampella, Dong Xia, Anne-Rachel Krostag, Pauline So, Unja Martin, Wai-Hang Leung, Alexander Astrakhan, Mark Pogson, Jordan Jarjour, Josh Gustafson, Michael CV Jensen
Journal: Blood
Blood (2021) 138 (Supplement 1): 905.
https://doi.org/10.1182/blood-2021-154461
Published: 2021
Journal Articles

SCRI-CAR19x22v2 T Cell Product Demonstrates Bispecific Activity in B-ALL

Colleen Annesley, Corinne Summers, Michael A. Pulsipher, Jodi L. Skiles, Amanda M. Li, Anant Vatsayan, Catherine Lindgren, Stephanie Mgebroff, Ashley Wilson, Wenjun Huang, Qian Vicky Wu, Josh Gustafson, Christopher Brown, Michael C. Jensen, Julie R. Park, Rebecca A Gardner
Journal: Blood
Blood (2021) 138 (Supplement 1): 470.
https://doi.org/10.1182/blood-2021-148881
Published: 2021
Journal Articles

Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic Leukemia

Rebecca Gardner, MD, Colleen Annesley, MD, Olivia Finney, PhD, Corinne Summers, MD, Adam J. Lamble, MD, Julie Rivers, MD, Kaelin Crews, Lauren Huang, Christopher Brown, Stephanie Mgebroff, Catherine Lindgren, Karen Spratt, PhD, Josh Gustafson, PhD, Adam Johnson, PhD, Julie R. Park, MD, Michael C. Jensen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 278.
https://doi.org/10.1182/blood-2018-99-113126
Published: 2018